Ciprofloxacin Otic Suspension (Otiprio) for Acute Otitis Externa

Date: August 13, 2018 Issue #:  1553Summary:  The FDA has approved a 6% otic suspension formulation of the fluoroquinolone antibiotic ciprofloxacin (Otiprio– Otonomy) for single-dose treatment of acute otitis externa (swimmer ' s ear) caused byPseudomonas aeruginosa orStaphylococcus aureus in patients≥6 months old.Otiprio was approved earlier for prophylaxis in children with bilateral otitis media with effusion who are undergoing tympanostomy tube placement.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Ciprodex Ciprofloxacin Dexamethasone Fluoroquinolones Hydrocortisone Neomycin Ocuflox Otiprio Otitis media Pseudomonas aeruginosa Stapylococcus aureus Source Type: research